| 2014-06 | A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EQUIVALENCE TRIAL COMPARING THE ETANERCEPT BIOSIMILAR, HD203, WITH ENBREL (R), IN COMBINATION WITH METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) | 배상철 |
| 2018-11 | Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis | 배상철 |
| 2015-02 | Recent advances in systemic lupus erythematosus genetics in an Asian population | 배상철 |
| 2013-11 | A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis | 배상철 |
| 2013-09 | Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study | 배상철 |
| 2019-03 | Relationship between cerebral microbleeds and white matter MR hyperintensities in systemic lupus erythematosus: a retrospective observational study | 배상철 |
| 2011-05 | Replicated association of a regulatory polymorphism in the interferon gamma gene with lupus susceptibility | 배상철 |
| 2016-06 | Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus | 배상철 |
| 2014-01 | Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al | 배상철 |
| 2014-11 | Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations | 배상철 |
| 2017-12 | The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs | 배상철 |
| 2014-02 | The Role of Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria | 배상철 |
| 2012-04 | Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis | 배상철 |
| 2016-02 | Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial | 배상철 |
| 2017-08 | Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatment | 배상철 |
| 2012-09 | Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study | 배상철 |
| 2018-03 | Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus | 배상철 |
| 2014-04 | Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease | 배상철 |
| 2020-01 | Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus | 배상철 |
| 2020-05 | Synergistic activation of NF-kappa B by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk | 배상철 |
